 |
The Journal of Neuroscience, May 10, 2006, 26(19):5167-5179; doi:10.1523/JNEUROSCI.0482-06.2006
Previous Article | Next Article 
Neurobiology of Disease
Reduction in Mitochondrial Superoxide Dismutase Modulates Alzheimer's Disease-Like Pathology and Accelerates the Onset of Behavioral Changes in Human Amyloid Precursor Protein Transgenic Mice
Luke Esposito,1,2
Jacob Raber,1
Lisa Kekonius,1
Fengrong Yan,1
Giu-Qiu Yu,1
Nga Bien-Ly,1
Jukka Puoliväli,1
Kimberly Scearce-Levie,1
Eliezer Masliah,3 and
Lennart Mucke1,2
1Gladstone Institute of Neurological Disease and 2Department of Neurology, University of California, San Francisco, California 94158, and 3Departments of Neurosciences and Pathology, University of California at San Diego, La Jolla, California 92093
Correspondence should be addressed to L. Mucke, Gladstone Institute of Neurological Disease, 1650 Owens Street, San Francisco, CA 94158. Email: Lmucke{at}gladstone.ucsf.edu
Alzheimer's disease (AD) is associated with accumulations of amyloid- (A ) peptides, oxidative damage, mitochondrial dysfunction, neurodegeneration, and dementia. The mitochondrial antioxidant manganese superoxide dismutase-2 (Sod2) might protect against these alterations. To test this hypothesis, we inactivated one Sod2 allele (Sod2+/) in human amyloid precursor protein (hAPP) transgenic mice, reducing Sod2 activity to 50% of that in Sod2 wild-type (Sod2+/+) mice. A reduction in Sod2 activity did not obviously impair mice without hAPP/A expression. In hAPP mice, however, it accelerated the onset of behavioral alterations and of deficits in prepulse inhibition of acoustic startle, a measure of sensorimotor gating. In these mice, it also worsened hAPP/A -dependent depletion of microtubule-associated protein 2, a marker of neuronal dendrites. Sod2 reduction decreased amyloid plaques in the brain parenchyma but promoted the development of cerebrovascular amyloidosis, gliosis, and plaque-independent neuritic dystrophy. Sod2 reduction also increased the DNA binding activity of the transcription factor nuclear factor B. These results suggest that Sod2 protects the aging brain against hAPP/A -induced impairments. Whereas reductions in Sod2 would be expected to trigger or exacerbate neuronal and vascular pathology in AD, increasing Sod2 activity might be of therapeutic benefit.
Key words: amyloid precursor protein; transgenic mice; superoxide dismutase-2; Alzheimer's disease; mitochondria; behavior
Received Sept. 22, 2005;
revised March 24, 2006;
accepted March 25, 2006.
Correspondence should be addressed to L. Mucke, Gladstone Institute of Neurological Disease, 1650 Owens Street, San Francisco, CA 94158. Email: Lmucke{at}gladstone.ucsf.edu
This article has been cited by other articles:

|
 |

|
 |
 
C. A. Massaad, T. M. Washington, R. G. Pautler, and E. Klann
Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease
PNAS,
August 11, 2009;
106(32):
13576 - 13581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dumont, E. Wille, C. Stack, N. Y. Calingasan, M. F. Beal, and M. T. Lin
Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease
FASEB J,
August 1, 2009;
23(8):
2459 - 2466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Dziewczapolski, C. M. Glogowski, E. Masliah, and S. F. Heinemann
Deletion of the {alpha}7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease
J. Neurosci.,
July 8, 2009;
29(27):
8805 - 8815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ranganathan, G. G. Harmison, K. Meyertholen, M. Pennuto, B. G. Burnett, and K. H. Fischbeck
Mitochondrial abnormalities in spinal and bulbar muscular atrophy
Hum. Mol. Genet.,
January 1, 2009;
18(1):
27 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Park, P. Zhou, R. Pitstick, C. Capone, J. Anrather, E. H. Norris, L. Younkin, S. Younkin, G. Carlson, B. S. McEwen, et al.
Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein
PNAS,
January 29, 2008;
105(4):
1347 - 1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wu, Md. R. Basha, B. Brock, D. P. Cox, F. Cardozo-Pelaez, C. A. McPherson, J. Harry, D. C. Rice, B. Maloney, D. Chen, et al.
Alzheimer's Disease (AD)-Like Pathology in Aged Monkeys after Infantile Exposure to Environmental Metal Lead (Pb): Evidence for a Developmental Origin and Environmental Link for AD
J. Neurosci.,
January 2, 2008;
28(1):
3 - 9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sharma, N. Sud, D. A. Wiseman, A. L. Carter, S. Kumar, Y. Hou, T. Rau, J. Wilham, C. Harmon, P. Oishi, et al.
Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol,
January 1, 2008;
294(1):
L46 - L56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. H. Cheng, K. Scearce-Levie, J. Legleiter, J. J. Palop, H. Gerstein, N. Bien-Ly, J. Puolivali, S. Lesne, K. H. Ashe, P. J. Muchowski, et al.
Accelerating Amyloid-beta Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models
J. Biol. Chem.,
August 17, 2007;
282(33):
23818 - 23828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Liu, R. Gnanasambandam, J. Benjamin, G. Kaur, P. B. Getman, A. J. Siegel, R. D. Shortridge, and S. Singh
Mutations in Cytochrome c Oxidase Subunit VIa Cause Neurodegeneration and Motor Dysfunction in Drosophila
Genetics,
June 1, 2007;
176(2):
937 - 946.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|